In the present study, we confirm previous observations17,24–26, that loss-of-function of TP53 (primarily through sequence mutations) and CDKN2A (through SCNA, promoter hypermethylation and sequence mutations) are the earliest changes in HNSCC development. Here, TP53 is linked to head and neck squamous cell carcinoma.